Medical News, Journals & Upcoming Events
Most Read Psychiatry Articles on JAMA Network
- Effects of a Blended Digital Therapy Targeting Reasoning on Paranoia April 7, 2021This randomized clinical trial investigates the effects and mechanisms of action of SlowMo, a digitally supported reasoning intervention, plus usual care compared with usual care only among individuals with clinical paranoia.
- Association of Childhood Insulin Levels and Body Mass Index With Mental Health Risks in Young Adults April 1, 2021This cohort study examines changes in fasting insulin levels and body mass index from childhood to age 24 years and the risk for psychiatric disorders in that cohort at age 24 years.
- Suicide Prevention in the COVID-19 Era April 1, 2021This Special Communication discusses what data and recent events during the first 6 months of the coronavirus disease 2019 pandemic reveal about specific effects on suicide risk and outlines actionable steps that policy makers, health care leaders, and organizational leaders can take to mitigate suicide risk during and after the pandemic.
- Psychiatry’s Myopia—Reclaiming the Social, Cultural, and Psychological in the Psychiatric Gaze April 1, 2021This Viewpoint proposes that psychiatry should more closely attend to the poverty, justice system involvement, and housing issues of people with serious mental illness, supporting this view with quotes from philosophers.
- Association of Psychiatric Disorders With Mortality Among Patients With COVID-19 April 1, 2021This cohort study examines the incidence of mortality in patients with COVID-19 who had premorbid diagnoses of schizophrenia spectrum, mood, or anxiety diagnoses.
JAMA Oncology Current Issue
- Trends in Industry Payments to US Oncologists Since the Open Payments Program, 2014 to 2019 March 1, 2021This cohort study of medical oncologists in the US examines trends in physician-level payments in 2014 to 2019 to determine if implementation of the Open Payments program is associated with changes in the frequency and value of industry-oncologist payments.
- Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Triple-Negative Breast Cancer—Reply March 1, 2021In Reply We would like to thank Arora et al for their interest in our PATTERN (adjuvant Platinum and Taxane in Triple-Negative Breast Cancer) randomized clinical trial and their thoughtful comments on the article. First, we agree with their statement that “the PATTERN trial adds to the evidence that an anthracycline-free regimen may be considered […]
- When the Signal From Phase 2 Research Should Be a Warning Sign March 1, 2021The article by Akamatsu and colleagues in this issue of JAMA Oncology describes a phase 2 randomized clinical trial that tests the value of adding the vascular endothelial growth factor inhibitor bevacizumab to osimertinib in 81 Japanese patients with EGFR mutation–positive advanced non–small cell lung cancer (NSCLC) and T790M mutation–positive acquired resistance on a prior […]
- Incidence of Cervical Cancer in Puerto Rico, 2001-2017 March 1, 2021This cohort study examines recent trajectories in the incidence of cervical cancer in Puerto Rico by age and among birth cohorts.
Upcoming Events
To receive information about upcoming events and the latest CE Activities, join our network.
Live Events
The New England Journal of Medicine | Primary Care/Hospitalist/Clinical Practice
- Remote Patient Monitoring — Overdue or Overused? April 10, 2021The Covid-19 pandemic has challenged clinicians to find innovative ways to provide essential services while minimizing risks for themselves and their patients. These approaches increasingly leverage remote patient monitoring (RPM), using technology to support treatment for chronic conditions. As…
- Closed Gastroschisis April 10, 2021In a male neonate born at 37 weeks of gestation, a narrow stalk of small bowel and proximal colon protruded through a 1.5-cm defect in the abdominal wall. A diagnosis of gastroschisis had been made antenatally on the basis of findings from prenatal ultrasonography. In the area where the bowel had…
- Ulceroglandular Tularemia April 8, 2021Figure 1.
- Sunken Nose April 8, 2021Figure 1.
- Vancomycin Infusion Reaction — Moving beyond "Red Man Syndrome" April 8, 2021In 1959, an article entitled "An Anaphylactoid Reaction to Vancomycin" hypothesized that vancomycin-induced histamine release from mast cells had clinical manifestations similar to those of anaphylaxis but less severe. The author named this reaction "Red Man Syndrome," reflecting the diffuse…
The New England Journal of Medicine Rheumatology
- Sunken Nose April 8, 2021Figure 1.
- Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis April 1, 2021Upadacitinib is an oral, reversible Janus kinase (JAK) inhibitor approved for the treatment of rheumatoid arthritis. Adalimumab is a tumor necrosis factor α inhibitor used to treat rheumatoid arthritis and psoriatic arthritis. In one trial involving patients with rheumatoid arthritis, upadacitinib…
- Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis March 25, 2021Atopic dermatitis is a common, chronic inflammatory skin disease associated with itch, pain, sleep disturbance, anxiety, depression, and increased health care utilization. When topical therapies are insufficient, treatment with systemic agents, including dupilumab and immunosuppressants, has been…
- Atopic Dermatitis March 25, 2021Atopic dermatitis is one of the most prevalent inflammatory skin diseases. It usually develops in childhood and may persist into adulthood; less frequently, it starts in midlife or late life. The disorder is characterized by recurrent, pruritic, localized eczema, often with seasonal fluctuations.…
